1.405
Acumen Pharmaceuticals Inc (ABOS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
|
37.47%
41.75
|
30.37 | 39.60 | 32.27 | 24.38 |
Operating Income/Loss |
37.47%
-41.75
|
-30.37 | -39.60 | -32.27 | -24.38 |
Nonoperating Income/Loss |
49.17%
0.80
|
1.574 | 2.443 | 2.50 | 3.844 |
Income/Loss From Continuing Operations Before Tax |
42.21%
-40.95
|
-28.80 | -37.15 | -29.77 | -20.54 |
Income/Loss From Continuing Operations After Tax |
42.21%
-40.95
|
-28.80 | -37.15 | -29.77 | -20.54 |
|
42.21%
-40.95
|
-28.80 | -37.15 | -29.77 | -20.54 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.08%
60.57
|
60.53 | 0.0224 | 60.08 | 60.08 |
Diluted Average Shares |
0.08%
60.57
|
60.53 | 0.0224 | 60.08 | 60.08 |
Basic Earnings Per Share |
41.67%
-0.68
|
-0.48 | -0.62 | -0.50 | -0.34 |
Diluted Earnings Per Share |
41.67%
-0.68
|
-0.48 | -0.62 | -0.50 | -0.34 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):